| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 |
| Total Revenue |
-
|
-
|
-
|
-
|
| Cost of Revenue |
-
| (66) | 66 |
-
|
|
| Gross Profit |
-
| 66 | (66) |
-
|
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative | 346 | 454 | 417 | 554 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others | 0 | 0 | 0 |
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (347) | (454) | (417) | (536) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 479 | 454 | 152 | 0 |
| Earnings Before Interest And Taxes | 133 | 0 | (265) | (536) |
| Interest Expense |
-
|
-
|
-
|
-
|
| Income Before Tax | 133 | 0 | (265) | (536) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | 133 | 0 | (265) | (536) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
| 17,156 | 254 |
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | 133 | 0 | 16,890 | (281) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | $133 | $0 | $16,890 | ($281) |
0.51% Nasdaq 
Income Statement
